According to the latest analysis by Fact.MR, the global peptide therapeutics market is standing at a critical inflection point, evolving from a niche pharmaceutical segment into a primary pillar of modern medicine. Valued at USD 140.9 billion in 2025, the sector is projected to reach USD 156.4 billion in 2026 and surge to USD 444.8 billion by 2036.

According to the latest analysis by Fact.MR, the global urinary catheters market is undergoing a significant transformation, evolving from a traditional commodity device segment into a value-driven category defined by material innovation and patient-centric design. As healthcare systems grapple with the dual challenges of an aging global populati